← Leaderboards
Adrienne C Lahti
University Of Maryland Baltimore
$11,053,313
Attributed
$12,616,037
Total exposure
10
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,616,037 · 10
By mechanism
R01$12,169,806 · 6
T32$423,874 · 1
M01$22,357 · 3
Top collaborators
- Yogesh Dwivedi3 shared
- Nina Vanessa Kraguljac2 shared
- Junghee Lee2 shared
Most similar at University Of Maryland Baltimore
Same institution · by research overlap
- Carol A. Tamminga$26,097,596
- L. Elliot Hong$24,654,132
- James M. Gold$25,110,473
- Deanna L Kelly$13,077,948
- Melanie E Bennett$13,032,333
Others in their field
Top investigators on “Schizophrenia”
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$104,668,216
- Raquel E Gur · University Of Pennsylvania$60,189,770
- Mark J Daly · Broad Institute, Inc.$48,989,393
- John M Kane · Long Island Jewish Medical Center$45,235,871
- Carrie E Bearden · University Of California Los Angeles$42,025,230
- Scott W Woods · Yale University$41,221,536
Research focus
SchizophreniaAntipsychotic AgentsBrainFunctional Magnetic Resonance ImagingTreatment ResponseResponseMagnetic Resonance SpectroscopyPsychotic DisordersPharmaceutical PreparationsGlutamatesIndexingPatternProtonsBrain ImagingBrain RegionEnrollmentFirst Episode PsychosisFunctional DisorderAffectRestRisperidoneCingulate CortexAnteriorNeurons
Grant awards (29)
Multidimensional aging trajectories in mid to late-life psychosis (MAP)$943,424
R01 · FY2025 · MH
4/5 Biomarkers to Enhance Early Schizophrenia Treatment (BEEST)$367,741
R01 · FY2025 · MH · contact PI
Predoctoral Training in Multifaceted Translational Approach to Mental Illness$152,497
T32 · FY2025 · MH · contact PI
Multidimensional aging trajectories in mid to late-life psychosis (MAP)$1,082,757
R01 · FY2024 · MH
4/5 Biomarkers to Enhance Early Schizophrenia Treatment (BEEST)$365,726
R01 · FY2024 · MH · contact PI
Predoctoral Training in Multifaceted Translational Approach to Mental Illness$187,388
T32 · FY2024 · MH · contact PI
Predoctoral Training in Multifaceted Translational Approach to Mental Illness$83,989
T32 · FY2023 · MH · contact PI
Trajectories of treatment response as window into the heterogeneity of psychosis: a longitudinal multimodal imaging study in medication-naieve first episode psychosis patients$805,537
R01 · FY2022 · MH · contact PI
Trajectories of treatment response as window into the heterogeneity of psychosis: a longitudinal multimodal imaging study in medication-naieve first episode psychosis patients$816,340
R01 · FY2021 · MH · contact PI
Trajectories of treatment response as window into the heterogeneity of psychosis: a longitudinal multimodal imaging study in medication-naieve first episode psychosis patients$816,340
R01 · FY2020 · MH · contact PI
Trajectories of treatment response as window into the heterogeneity of psychosis: a longitudinal multimodal imaging study in medication-naieve first episode psychosis patients$743,707
R01 · FY2019 · MH · contact PI
Trajectories of treatment response as window into the heterogeneity of psychosis: a longitudinal multimodal imaging study in medication-naieve first episode psychosis patients$735,068
R01 · FY2018 · MH · contact PI
Glutamate, brain connectivity and duration of untreated psychosis$559,356
R01 · FY2018 · MH · contact PI
Glutamate, brain connectivity and duration of untreated psychosis$559,356
R01 · FY2017 · MH · contact PI
Glutamate, brain connectivity and duration of untreated psychosis$559,356
R01 · FY2016 · MH · contact PI
Glutamate, brain connectivity and duration of untreated psychosis$559,356
R01 · FY2015 · MH · contact PI
Glutamate, brain connectivity and duration of untreated psychosis$631,795
R01 · FY2014 · MH · contact PI
Treatment response in schizophrenia: bridging imaging and postmortem studies$344,520
R01 · FY2013 · MH · contact PI
Treatment response in schizophrenia: bridging imaging and postmortem studies$358,875
R01 · FY2012 · MH · contact PI
Treatment response in schizophrenia: bridging imaging and postmortem studies$358,875
R01 · FY2011 · MH · contact PI
Treatment response in schizophrenia: bridging imaging and postmortem studies$362,500
R01 · FY2010 · MH · contact PI
Treatment response in schizophrenia: bridging imaging and postmortem studies$362,500
R01 · FY2009 · MH · contact PI
CEREBRAL BLOOD FLOW (CBF) &CEREBRAL ELECTRICAL ACTIVITY DURING BEHAVIORAL TASKS$2,952
M01 · FY2005 · RR
3P8WKCIOZ$95
M01 · FY2005 · RR
Cerebral Blood Flow/Electrical Activity--Behavior Tasks$18,804
M01 · FY2004 · RR
(S)-3-3(3-Hydroxphyenl)-N Propylpiperdine Hydrochloride$506
M01 · FY2004 · RR
BLOOD FLOW CHANGES AND ANTIPSYCHOTIC DRUG ACTION$286,928
R01 · FY2002 · MH
BLOOD FLOW CHANGES AND ANTIPSYCHOTIC DRUG ACTION$278,932
R01 · FY2001 · MH
BLOOD FLOW CHANGES AND ANTIPSYCHOTIC DRUG ACTION$270,817
R01 · FY2000 · MH